Klaria Pharma Holding AB (publ.) Balance Sheet Health
Financial Health criteria checks 6/6
Klaria Pharma Holding AB (publ.) has a total shareholder equity of SEK12.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK64.4M and SEK51.4M respectively. Klaria Pharma Holding AB (publ.)'s EBIT is SEK1.3M making its interest coverage ratio 0.1. It has cash and short-term investments of SEK537.0K.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | 0.1x |
| Cash | SEK 537.00k |
| Equity | SEK 12.92m |
| Total liabilities | SEK 51.44m |
| Total assets | SEK 64.36m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6FN's short term assets (SEK64.3M) exceed its short term liabilities (SEK51.4M).
Long Term Liabilities: 6FN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 6FN is debt free.
Reducing Debt: 6FN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 6FN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 6FN is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 5% per year.